Technological advances in renal replacement therapy: five years and beyond.
The worldwide epidemic of chronic kidney disease shows no signs of abating in the near future. Current dialysis forms of renal replacement therapy (RRT), even though successful in sustaining life and improving quality of life somewhat for patients with ESRD, have many limitations that result in still unacceptably high morbidity and mortality. Transplantation is an excellent option but is limited by the scarcity of organs. An ideal form of RRT would mimic the functions of natural kidneys and be transparent to the patient, as well as affordable to society. Recent advances in technology, although generally in early stages of development, might achieve these goals. The application of nanotechnology, microfluidics, bioreactors with kidney cells, and miniaturized sorbent systems to regenerate dialysate makes clinical reality seem closer than ever before. Finally, stem cells hold much promise, both for kidney disease and as a source of tissues and organs. In summary, nephrology is at an exciting crossroad with the application of innovative and novel technologies to RRT that hold considerable promise for the near future.
Rastogi
Anjay
A
Department of Medicine, University of California, Los Angeles, CA 90095, USA. arastogi@mednet.ucla.edu
Nissenson
Allen R
AR
D021522:Bioartificial Organs / Q000639:trends; D004059:Diffusion of Innovation; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D016030:Kidney Transplantation / Q000639:trends; D007688:Kidneys, Artificial / Q000639:trends; D036103:Nanotechnology / Q000639:trends; D006435:Renal Dialysis / Q000639:trends; D017582:Renal Replacement Therapy / Q000639:trends*; D033581:Stem Cell Transplantation / Q000639:trends; D013997:Time Factors; D023822:Tissue Engineering / Q000639:trends; D016896:Treatment Outcome